Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:01 PM UTC
| NCT Number | NCT06989112 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 63 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 13, 2026 (2 days ago) |
As of October 15, 2026: Clinical trial NCT06989112 is currently recruiting participants. This phase3 study for endometrial cancer is actively seeking new participants at 63 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06989112 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06989112 was last updated 2 days ago (October 13, 2026). HelloStudys verifies this status automatically.